Polyunsaturated fatty acid supplementation for drug-resistant epilepsy

  • Protocol
  • Intervention

Authors

  • Vivian Sarmento Vasconcelos,

    1. UNCISAL (Universidade Estadual de Ciencias de Saude de Alagoas), Maceio, Alagoas, Brazil
    Search for more papers by this author
  • Cristiane R Macedo,

    Corresponding author
    1. Centro de Estudos de Medicina Baseada em Evidências e Avaliação Tecnológica em Saúde, Brazilian Cochrane Centre, São Paulo, São Paulo, Brazil
    • Cristiane R Macedo, Brazilian Cochrane Centre, Centro de Estudos de Medicina Baseada em Evidências e Avaliação Tecnológica em Saúde, Rua Borges Lagoa 564 cj 63, São Paulo, São Paulo, CEP 04038-000, Brazil. crisrufa@uol.com.br.

    Search for more papers by this author
  • Alexsandra Souza Pedrosa,

    1. University of Health Sciences of Alagoas - UNCISAL, Physiotherapy, Maceió, Brazil
    Search for more papers by this author
  • Edna Pereira Gomes Morais,

    1. Universidade Estadual de Ciências da Saúde Alagoas - UNCISAL, Propaedeutic and Therapeutic Sciences, Maceió, Alagoas, Brazil
    Search for more papers by this author
  • Maria R Torloni

    1. Centro de Estudos de Medicina Baseada em Evidências e Avaliação Tecnológica em Saúde, Brazilian Cochrane Centre, São Paulo, São Paulo, Brazil
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effectiveness and safety of PUFA supplementation compared to no supplementation, placebo or other treatments for controlling convulsions in patients with drug-resistant epilepsy.

Ancillary